Gut bacteria could hold key to better epilepsy treatment

NCT ID NCT07253701

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study looks at how bacteria in the gut and mouth are linked to epilepsy and whether they affect how well seizure medicines work. Researchers will collect stool, saliva, and blood samples from 1,500 people with newly diagnosed epilepsy and healthy controls. By analyzing these samples, they hope to find patterns that could one day help doctors personalize epilepsy treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could help doctors choose the best seizure medicine based on a person's gut bacteria, improving seizure control and reducing side effects.
What could go wrong
This is an observational study, not a treatment trial. It may find no clear links between gut bacteria and epilepsy, or the results may not lead to practical changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOMARKER DISCOVERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akademiska Sjukhuset

    RECRUITING

    Uppsala, Sweden

  • Drottning Silvias Barnsjukhus

    RECRUITING

    Gothenburg, Sweden

  • Karolinska Universitetssjukhus

    RECRUITING

    Stockholm, Sweden

  • Norrlands universitetssjukhus

    RECRUITING

    Umeå, Sweden

  • Skånes universitetssjukhus

    RECRUITING

    Lund, Sweden

  • Universitetssjukhuset i Linköping

    RECRUITING

    Linköping, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.